Doxycycline (Vibramycin)

Subscribe to Selected New Research on Doxycycline

2421 relevant articles (347 outcomes, 389 trials/studies) found for this Drug

Description: A synthetic TETRACYCLINE derivative with similar antimicrobial activity. Animal studies suggest that it may cause less tooth staining than other tetracyclines. It is used in some areas for the treatment of chloroquine-resistant falciparum malaria (MALARIA, FALCIPARUM).

Also Known As:

Vibramycin; BMY-28689; BU-3839T; CollaGenex Brand of Doxycycline; Doxycycline Calcium; Doxycycline Calcium Salt (1:2); Doxycycline Monohydrate; Doxycycline Monohydrochloride, 6-epimer; Doxycycline Monohydrochloride, Dihydrate; Doxycycline Phosphate (1:1); Doxycycline-Chinoin; Hydramycin; Oracea; Vibramycin Novum; Vibravenos; alpha-6-Deoxyoxytetracycline; BMY 28689; BMY28689; BU 3839T; BU3839T; Dihydrate Doxycycline Monohydrochloride; Doxycycline Chinoin; Doxycycline CollaGenex Brand; Doxycycline Monohydrochloride, 6 epimer; Monohydrochloride, Dihydrate Doxycycline; Novum, Vibramycin; alpha 6 Deoxyoxytetracycline; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-

Relationship Network

Drug Context: Research Results

Experts

1.	Hoerauf, Achim: 8 articles (09/2008 - 04/2003)
2.	Mand, Sabine: 7 articles (09/2008 - 04/2003)
3.	Adjei, Ohene: 6 articles (09/2008 - 04/2003)
4.	Sorsa, Timo: 6 articles (08/2008 - 01/2004)
5.	Bradshaw, Mark H: 6 articles (03/2008 - 07/2002)
6.	Debrah, Alexander Yaw: 5 articles (09/2008 - 11/2003)
7.	Marfo-Debrekyei, Yeboah: 5 articles (09/2008 - 04/2003)
8.	Golub, Lorne M: 5 articles (08/2008 - 03/2004)
9.	Atilla, Gül: 5 articles (03/2008 - 01/2004)
10.	Preshaw, Philip M: 5 articles (03/2008 - 08/2004)

Related Diseases

1.	Infection 12/01/2007 - "The infection resolved completely after successful treatment with doxycycline for 6 months. " 10/01/1999 - "The findings show that doxycycline intervention of infection, although very effective in eradicating chlamydiae from genital tissue and preventing upper genital tract disease, significantly inhibits the development of protective immunity. " 12/01/2009 - "muris-primed mice treated with doxycycline showed significantly greater susceptibility to challenge infection with IOE compared to untreated mice persistently infected with E. " 04/01/2008 - "CONCLUSIONS: The results suggest that doxycycline is beneficial in reducing membrane-associated infection and can potentiate regeneration through host modulation." 01/01/1998 - "Therapeutic efficacy of doxycycline against experimental Pasteurella multocida infection in broiler chickens." Order ALL the reference details at left...
2.	Brucellosis (Malta Fever) 05/21/1994 - "[Meta-analysis of the efficacy of the combination of +rifampicin and doxycycline in the treatment of human brucellosis]" 12/01/2005 - "METHODS: Four patients with brucellosis developed yellow-brown discolouration of teeth following a 30-45 day course of doxycycline therapy during summer at a dose of 200mg/day. " 12/01/2005 - "BACKGROUND: Doxycycline is the most effective antibiotic for managing brucellosis. " 04/14/2005 - "We discuss the relationship between brucellosis, AIH, and hepatotoxicity of doxycycline. " 04/14/2005 - "Only one case of AIH probably caused by doxycycline and brucellosis was reported. " Order ALL the reference details at left...
3.	Urethritis 03/01/2002 - "The regimen of 100 mg. doxycycline orally twice daily for 7 days, which is recommended for chlamydial nongonococcal urethritis, seems to be effective for M. " 01/01/1986 - "The efficacy of doxycycline in the treatment of chlamydial urethritis was evaluated in 106 patients. " 01/01/1986 - "[Clinical studies on doxycycline in the treatment of nongonococcal urethritis by Chlamydia trachomatis]" 11/01/1985 - "[Clinical studies on doxycycline in male nongonococcal urethritis]" 01/01/1980 - "Doxycycline in the treatment of chlamydial urethritis: a therapeutic study." Order ALL the reference details at left...
4.	Rosacea (Acne Rosacea) 07/01/2007 - "Is low-dose doxycycline effective for rosacea?" 05/01/2007 - "CONCLUSION: Once-daily anti-inflammatory dose doxycycline appears to be effective and safe for the treatment of rosacea." 05/01/2007 - "BACKGROUND: Doxycycline monotherapy at antimicrobial doses has been shown to be effective for the treatment of rosacea. " 08/01/2009 - "Anti-inflammatory dose doxycycline in particular allows for a safe and effective short- and long-term therapy of rosacea. " 09/01/2007 - "BACKGROUND: Two large clinical trials have recently demonstrated the efficacy of a 40-mg controlled-release formulation of doxycycline in the treatment of rosacea, a dose well below the conventional level of 100 to 200 mg/d. " Order ALL the reference details at left...
5.	Lyme Disease (Disease, Lyme) 01/01/2008 - "Oral doxycycline, also effective against coinfection with Anaplasma phagocytophilum, is the mainstay of therapy of cutaneous manifestations of Lyme borreliosis. " 07/12/2001 - "METHODS: In an area of New York where Lyme disease is hyperendemic we conducted a randomized, double-blind, placebo-controlled trial of treatment with a single 200-mg dose of doxycycline in 482 subjects who had removed attached I. scapularis ticks from their bodies within the previous 72 hours. " 05/01/2006 - "In endemic areas, documentation of coinfection with Borrelia burgdorferi, the etiologic agent of Lyme disease, may require prolonging the duration of doxycycline therapy." 03/01/2006 - "Tick control can include a product that repels or protects against tick attachment, thereby helping to prevent transmission of coinfections as well as Borrelia spp. Seropositive dogs with clinical abnormalities thought to arise from Lyme disease generally are treated with doxycycline (10 mg/kg q24h for 1 month). " 11/01/2001 - "Single-dose doxycycline for the prevention of Lyme disease." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Rifampin (Rifampicin)
2.	Tetracycline (Achromycin)
3.	Azithromycin (Zithromax)
4.	Ciprofloxacin (Cipro)
5.	Amoxicillin (Wymox)
6.	Anti-Bacterial Agents (Antibiotics)
7.	Ceftriaxone (Ceftriaxon)
8.	Minocycline (Cyclops)
9.	Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
10.	Ofloxacin (Levofloxacin)

Related Therapies and Procedures

1.	Root Planing
2.	Sclerotherapy
3.	Pleurodesis
4.	Palliative Care (Palliative Medicine)
5.	Drug Therapy (Chemotherapy)

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 14726 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>